Dan Nakano

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura, Mohammed Eslam, Takumi Kawaguchi et al. · Liver International · 2020 · 409 citations · Full text

Medicine, Internal Medicine, Pathology +17

MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach

Tsubasa Tsutsumi, Mohammed Eslam, Takumi Kawaguchi et al. · Hepatology Research · 2021 · 174 citations · Full text

Medicine, Cardiology, Epidemiology +16

Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

Takumi Kawaguchi, Michael Charlton, Atsushi Kawaguchi et al. · Seminars in Liver Disease · 2021 · 115 citations

Medicine, Endocrinology, Nutritional Sciences +17

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)

Dan Nakano, Takumi Kawaguchi, Hideki Iwamoto et al. · PLoS ONE · 2020 · 85 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events

Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose et al. · Cancers · 2020 · 68 citations · Full text

Medicine, Oncology, Pharmacology +16